Share on LinkedInShare on LinkedIn

ARTICLE · 22 JULY 2025

FDA Announces AI Councils Amid Calls For Greater Agency Transparency

Akin
Akin
Contributor
Akin

Akin

Akin is a global law firm with more than 1,100 lawyers and advisors who pride themselves on...

View firm profile
Explore more from Akin

The agency's internal usage of AI has been of particular interest in the last few months after the agency's announcement in May that its first AI-assisted scientific review pilot was successful and directing all FDA centers to begin integrating certain AI-generated capabilities within FDA's internal data platforms by the end of the following month.

United StatesTechnology

Recently, it was reported that the U.S. Food and Drug Administration (FDA) is launching two cross-agency artificial intelligence (AI) councils. One AI council will be tasked with addressing how the agency uses AI internally and the other will focus on policy governing AI's use in FDA-regulated products (reportedly pre-existing AI councils in various FDA divisions will continue to operate) (Politico Pro).

The agency's internal usage of AI has been of particular interest in the last few months after the agency's announcement in May that its first AI-assisted scientific review pilot was successful and directing all FDA centers to begin integrating certain AI-generated capabilities within FDA's internal data platforms by the end of the following month. Then, in June, FDA launched Elsa, a generative AI tool designed to help employees work more efficiently. According to FDA, Elsa is designed to prepare information so that FDA staff can make decisions more efficiently, and

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from